ketanserin has been researched along with 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christoffersen, M; Erritzoe, D; Frokjaer, VG; Holst, KK; Jernigan, TL; Johansen, SS; Knudsen, GM; Madsen, J; Ramsøy, T; Rasmussen, PM; Svarer, C | 1 |
1 other study(ies) available for ketanserin and 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile
Article | Year |
---|---|
In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
Topics: Adult; Amphetamine-Related Disorders; Aniline Compounds; Brain; Case-Control Studies; Cross-Sectional Studies; Female; Fluorine Radioisotopes; Hallucinogens; Humans; Ketanserin; Male; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Protein Binding; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Serotonin Plasma Membrane Transport Proteins; Sulfides | 2011 |